NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»18/08/2009 [Industry news]
TCM for hepatic fibrosis starts phase II trials at UCSD School of Medicine

Fuzheng Huayu tablet, a traditional Chinese medicine (TCM) for the treatment of hepatic fibrosis in patients with hepatitis C, has received approval from the Institutional Review Board (IRB) of the University of California, San Diego School of Medicine to conduct clinical trials

 
Fuzheng Huayu tablet, a traditional Chinese medicine (TCM) for the treatment of hepatic fibrosis in patients with hepatitis C, has received approval from the Institutional Review Board (IRB) of the University of California, San Diego School of Medicine to conduct clinical trials, according to Xinmin Evening News August 17. The full title of the study is: A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis. The tablet received US Food and Drug Administration (FDA) approval to conduct clinical studies on its effectiveness on hepatic fibrosis two years ago. The UC San Diego School of Medicine was founded in 1966 and is consistently rated as one of the foremost medical training institutions in the United States.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.